Suzano
- Market cap
- 10.37B
- P/E (TTM)i
- 6.37
- P/Bi
- 1.05
- EPSi
- 2.16
- Div yieldi
- 2.68%
- 52W posi
- 22%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Paper & Paper Products
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Suzano (SUZ) | 10.37B | 6.37 | 1.05 | 2.68% |
| Sylvamo (SLVM) | 1.26B | 16.99 | 1.32 | 7.08% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 37.6% below Morningstar's fair value estimate.
Fair value
At face value, Suzano SA looks inexpensive, following a substantial price decline over the past year. To account for the risk of a possible value trap, we have capped its rating at 3 stars. The stock currently trades at a 27% discount to our quantitative fair value estimate of $11.59 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's valuation metrics bolster our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 90.9% falls in the top 40% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.
The firm's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 4.3, a core component of leverage, falls in the bottom 30% compared with peers globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.
Economic moat
The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-08 04:04:31 · For reference only, not investment advice and not tailored to your situation.